NEW YORK (GenomeWeb News) – Nanosphere reported after the close of the market Wednesday that its full-year revenues more than doubled and it trimmed its annual loss.

The firm also announced a management shakeup, which includes the naming of a new CEO and the replacement of several board members. Wall Street reacted negatively to the changes and a revenue forecast below expectations, sending the firm's shares tumbling 30 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

The House of Lords in the UK approves a bill to allow mitochondrial donation.